Odyssey Health (ODYY) Cash from Operations (2014 - 2026)
Odyssey Health (ODYY) reported Cash from Operations of 318521.0 for Q2 2026, down 7861.03% year-over-year from 4104.1 in Q2 2025, and down 12.05% sequentially from 284259.0 in Q1 2026.
Odyssey Health (ODYY) Cash from Operations (2014 - 2026) Analysis & Trends
Odyssey Health has disclosed Cash from Operations across 13 years of filings, most recently posting 318521.0 for Q2 2026.
- Quarterly Cash from Operations fell 7861.03% year-over-year to 318521.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 934977.0 (down 157.69% YoY) and the FY2025 annual result came in at 347392.0, up 71.41% from the prior year.
- Cash from Operations eased to 318521.0 in Q2 2026, from 284259.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 1080115.0 in Q3 2022 and bottomed at 970018.0 in Q2 2022.
- The 5-year median for Cash from Operations is 216323.5 (2024), against an average of 235197.89.
- Year-over-year, Cash from Operations jumped 251.16% in 2022 and sank 7861.03% in 2026.
- Odyssey Health's Cash from Operations stood at 284707.0 in 2022, then soared by 78.96% to 59907.0 in 2023, then tumbled by 314.83% to 248514.0 in 2024, then decreased by 14.28% to 283998.0 in 2025, then fell by 12.16% to 318521.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 318521.0, 284259.0, and 283998.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 2.74 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 220.10 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 525.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 335.40 Mn |
| 10 | Odyssey Health | - | - | - | -318,521.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -318,521.00 |
| Apr 30, 2026 | -318,521.00 |
| Jan 31, 2026 | -284,259.00 |
| Jan 31, 2026 | -284,259.00 |
| Oct 31, 2025 | -283,998.00 |
| Oct 31, 2025 | -283,998.00 |
| Jul 31, 2025 | -48,199.00 |
| Jul 31, 2025 | -48,199.00 |
| Apr 30, 2025 | -4,001.00 |
| Apr 30, 2025 | -4,001.00 |
| Jan 31, 2025 | -46,678.00 |
| Jan 31, 2025 | -46,678.00 |
| Oct 31, 2024 | -248,514.00 |
| Oct 31, 2024 | -248,514.00 |
| Jul 31, 2024 | -63,635.00 |
| Jul 31, 2024 | -63,635.00 |
| Apr 30, 2024 | -184,133.00 |
| Apr 30, 2024 | -184,133.00 |
| Jan 31, 2024 | -907,535.00 |
| Jan 31, 2024 | -907,535.00 |